论文部分内容阅读
资料与方祛：１．对象：ｓｌ例慢性乙型肝炎患者，其中１７例经肝穿证实。年龄１４－４８岁。男性６４例，女性１７例。血清ＨＢＶＤＮＡ均阳性（ＰＣＲ法），ＡＬＴ均升高。６７例ＨＢｅＡｇ阳性，１４例抗一ＨＢｅ阳性。２．治疗方法：用以ｆｏ－１＊Ｎ（深圳科兴生物制品有
Data and side cured: 1. Subjects: sl patients with chronic hepatitis B, of which 17 cases confirmed by the liver. Age 14-48 years old. 64 males and 17 females. Serum HBVDNA were positive (PCR method), ALT were elevated. 67 cases of HBeAg positive, 14 cases of anti-HBe positive. 2. Treatment: to fo-1 * N (Shenzhen Kexing biological products have